By Sheeba M. | April 30, 2026
Trulieve Stock Rally Stalls as Debt Concerns Resurface Ahead of Q1 Earnings
Debt Load Looms Over Florida’s Cannabis Leader
Trulieve Cannabis (TCNNF), the nation’s largest MSO by store count, has seen its recent rally lose steam as credit concerns resurface. The company carries approximately $4.2 billion in gross debt—manageable relative to EBITDA, but significant enough to trigger refinancing risk if rates remain elevated.
Analysts are watching the May 15 Q1 earnings call closely for guidance on debt repayment timelines and potential asset sales. Trulieve (TCNNF) management has previously signaled a desire to improve the capital structure, but execution has been slower than expected.
Bright Spots: Florida Medical Momentum
On the positive side, Trulieve’s Florida medical cannabis business continues to thrive, with comparable store sales up 8% year-over-year. The company’s retail footprint expansion in Arizona and Pennsylvania is also on track. If Q1 revenues exceed $760M and gross margins hold above 54%, the stock could break through $25.
Key Numbers to Watch
- Revenue: Consensus $758M vs. Company guidance $760M+ (upside = tailwind)
- Gross margin: Watch for sub-54% signals caution, 55%+ is bullish
- Debt reduction: Any debt paydown of $200M+ signals confidence
- Comparable store sales: Florida comp growth >7% = story intact
Sources
- Trulieve Investor Relations — Q1 2026 earnings guidance
- SEC EDGAR — 10-Q and debt covenants
- Benzinga — Cannabis sector debt analysis
Track cannabis stocks with the Weedstock Real-Time Tracker